Fresenius Medical Care AG KGaA
- FMS
- NYSE
- Consumer Products
- Latest 34.32
- Currency US$
- Change -0.03
- Percent Change -0.087 %
- Volume 138,360
- Wed May 22, 2013 4:05 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 34.61
- Previous Close 34.35
- High 35.03
- Low 34.30
- Bidx 34.56
- Askx 34.60
- 52-week High -- 39.10
- 52-week Low -- 31.785
- Beta 1.102
- Market Cap 21,052.92M
- EPS 3.50
- P/E 9.81
- Forward P/E 17.333
- PEG 1.63
- Annual Dividend 0.49
- Yield 1.429
News
- Fresenius Medical Care Prepared to Provide Uninterrupted Care for Dialysis Patients with the Onset of an Active Storm Season
- Fresenius Medical Care Wins Multiple National Awards for Outstanding Patient Case Management
- Apollo Medical Holdings and Fresenius Medical Care Partner to Improve the Health of ApolloMed ACO Patients with End-Stage Renal Disease
- Fresenius Medical Care Wins Modern Healthcare Award for its Innovative Program to Improve Dialysis Patients' Quality of Life
- Heritage California ACO and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients in Southern California
Financials & Calendars
- Sales $13,800,280,000
- Earnings $1,186,810,000
- Return on Equity 12.38%
- Cash Flow --
- Cash $688,040,000
- Current Ratio 1.93
12 months ended Dec 31, 2012.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $22,325,990,000
- Liabilities $12,595,470,000
- Liabilities-to-Equity Ratio 1.29
Price Ratios
- Price to Sales 1.53
- Price to Book 2.16
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 30 | $0.45 | Aug 7 | $0.46 |
| Surprises | Apr 30 | -17.78% | n/a | n/a |
| Dividends | May 14 | $0.49 | n/a | n/a |
| Splits | Dec 4 | 2:1 | n/a | n/a |
12 months ended May 23, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture a range of hemodialysis machines, dialyzers, peritoneal dialysis solutions and ancillary products. They have operations in approximately 100 countries.
Officers
- Rice Powell Chief Executive Officer & Chai
- Michael Brosnan Chief Financial Officer
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Ideas & Discussion
Live Discussion of FMS on StockTwits